We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PBF:NYSEPBF Energy Inc. Analysis

Data as of 2026-07-21 - not real-time

$63.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

PBF Energy is trading at $63.85, essentially at its 52‑week high of $64.67 and just below the calculated resistance level. The stock sits comfortably above its 20‑day ($50.76) and 50‑day ($44.88) SMAs, confirming a bullish technical backdrop, while the MACD histogram remains positive. However, the RSI of 79 indicates the shares are *overbought* and vulnerable to a short‑term pullback. Fundamentally, the company’s revenue grew 12% YoY, yet margins are razor‑thin (gross margin 1.8%, operating margin –1.3%) and free cash flow is negative, leaving a DCF fair value of only $7.17—a **22% downside** from the current price. The dividend yield of 1.72% is supported by a modest 29% payout ratio, but the high debt‑to‑equity of 63.7% and a beta that skews slightly negative add to the risk profile. Upcoming Q2 earnings on July 30 and recent insider sales of over 1.2 million shares inject additional uncertainty. Overall, while the short‑term technicals appear strong, the valuation gap, cash‑flow weakness, and sector cyclicality suggest caution moving forward.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory signaling near‑term downside
  • Proximity to resistance level and limited upside
  • Imminent earnings release adding volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Thin operating margins and negative free cash flow
  • Stable dividend yield providing some income cushion

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • High debt load and exposure to energy‑transition regulatory pressure
  • Persistent overvaluation relative to fundamentals
  • Volatile earnings and cash‑flow profile in a cyclical sector

Key Metrics & Analysis

Financial Health

Revenue Growth11.90%
Profit Margin1.46%
P/E Ratio16.8
ROE8.18%
ROA-1.97%
Debt/Equity63.72
P/B Ratio1.4
Op. Cash Flow$259.7M
Free Cash Flow$-884350016
Industry P/E21.5

Technical Analysis

TrendBullish
RSI79.2
Support$36.42
Resistance$64.67
MA 20$50.76
MA 50$44.88
MA 200$38.16
MACDBullish
VolumeStable
Fear & Greed Index89.7

Valuation

Fair Value$7.17
Target Price$49.62
Upside/Downside-22.29%
GradeOvervalued
TypeBlend
Dividend Yield1.72%

Risk Assessment

Beta-0.42
Volatility61.47%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.